slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 10,111-10,140
Pages 463
Rows per page 30
Component
10,111-10,140 of 13,863
09
The slide uses a process flow to explain the technical solution.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
33
The chart uses a horizontal bar structure to represent stages of development.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
41
The slide uses a bracket to highlight which members of the leadership team are speaking today.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
86
The slide uses molecular visualization of RBD mutations and a table showing KD (binding affinity) values, highlighting the poor binding (607 nM) to the beta variant.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
99
The chart is a dot plot showing affinity (KD) vs edit distance from parent binder. The benchmark is a horizontal dashed line.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
108
The chart uses a horizontal bar format to represent development progress against a timeline of stages (Target Eval to IND).Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
18
The slide showcases five distinct protein-antibody complex structures to demonstrate the versatility of the de novo design platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
13
The slide uses a stepped process diagram to illustrate dose escalation cohorts.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The chart illustrates the revenue contribution of four specific products (VIVITROL, ARISTADA, VUMERITY, LYBALVI) over time.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
22
The chart uses a split x-axis to show pre-dose baseline and post-dose results. The 8mg dose maintains maximum sleep latency (40 min) for the duration of the test.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
15
The chart highlights the total share count and the split between common shares and stock-based awards, with a focus on dilution management.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
07
Uses a geographic map and a nested circle diagram to illustrate the treatment gap.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
105
The chart highlights the long-term nature of royalty revenue, with a specific callout for products launched in the early 1990s.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
05
The slide uses a map-based visualization to show regional performance, with callout bubbles for percentage change and bar charts for absolute volume.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
04
The chart uses a stacked bar format to show Revenue (dark purple) and Operating Income (light purple) over time.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Attention1 hit
05
Includes a break in the x-axis between FY19 and FY22.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Attention1 hit
12
The slide highlights whitespace and underpenetrated markets in the US and Canada.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Financials1 hit
28
The chart illustrates deepening responses over time in a clinical trial setting.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
58
The slide uses a bar chart comparison to benchmark existing market leaders against placebo outcomes.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
09
The slide presents two line charts: one comparing BGM vs Invasive CGM, and one showing raw sugarBEAT data.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
10
Graphs depict prespecified statistical sensitivity analysis for moderate-to-severe patients (n=100; baseline HAMD-17 >= 22).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · ComplicationLoop · Cost Of Inaction1 hit
14
The table uses a color-coded legend for 'Degree of preference' (High, Medium, Low).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
32
The slide uses two line charts to visualize clinical trial data with p-values and delta LSM values.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
09
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Desire1 hit
11
The slide uses a waterfall-style bar chart to show performance improvement over time.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Action1 hit
10
Includes a legend for extraordinary items and a disclaimer regarding non-GAAP adjustments for FY 2022.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
16
The chart highlights the acquisition of Crestmark in 2018.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
19
The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable Disease).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
29
Includes a donut chart showing showroom distribution and detailed callouts for specific regions.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit